PHRR221013-004996
A Phase 3/3b, Randomized, Observer-blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine Compared to a Quadrivalent Influenza Vaccine in Adults ≥65 Years of Age
Seqirus UK Limited·Phase 3·Philippine Health Research RegistrySuspended
Study focus
- Disease/Condition
- Influenza
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Seqirus UK Limited
- Location
- Bangladesh;Bulgaria;Colombia;Estonia;Lithuania;Philippines;Poland;Romania;Serbia;Turkey
Timeline & enrollment
- Phase
- Phase 3
- Start date
- Apr 15, 2024
- End date
- N/A
ICD-10 classifications
Influenza and pneumoniaInfluenza due to identified seasonal influenza virusInfluenza with other manifestations, seasonal influenza virus identifiedInfluenza with pneumonia, seasonal influenza virus identifiedInfluenza due to identified zoonotic or pandemic influenza virus
Data source
- Registry
- Philippine Health Research Registry
- Trial ID
- PHRR221013-004996
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for PHRR221013-004996 through Pure Global AI's free database. This Phase 3 trial is sponsored by Seqirus UK Limited and is currently Suspended. The study focuses on Influenza.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Philippine Health Research Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.